Natco Pharma Ltd - Company Profile
Powered by 
All the data and insights you need on Natco Pharma Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Natco Pharma Ltd Strategy Report
- Understand Natco Pharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Natco Pharma Clinical Trials
Determine Natco Pharma Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Natco Pharma Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Prospective, Randomized, Parallel, Multicentric, Phase II/III Clinical Trial of Molnupiravir 800 mg Capsules and Standard of Care (SOC) Compared to Standard of Care Only in Confirmed RT-PCR Positive Patients With Moderate COVID-19 | GDCT0455521 | molnupiravir | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Phase II/III | Planned | Natco Pharma Ltd |
| Study to Evaluate the Safety and Efficacy of Oral NRC-2694-a in Combination with Paclitaxel in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or after Immune Checkpoint Inhibitor Therapy | GDCT0450764 | NRC-2694 | Oncology | Head And Neck Cancer Squamous Cell Carcinoma; Hypopharyngeal Cancer; Laryngeal Cancer; Oral Cavity (Mouth) Cancer; Oropharyngeal Cancer; Recurrent Head And Neck Cancer Squamous Cell Carcinoma | Phase II | Ongoing, recruiting | Natco Pharma Ltd |
| Bioequivalence Study of Olaparib Tablets 150 Mg with Lynparza (Olaparib) Tablets 150 mg in Male or Female Patients with Ovarian Cancer or Breast Cancer or Prostate Cancer | GDCT0430302 | olaparib | Oncology | Breast Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Malignant Neoplasms; Ovarian Cancer; Peritoneal Cancer; Prostate Cancer | Phase I | Ongoing, not recruiting | Natco Pharma Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer